Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease

Seth A Reasoner1, Maribeth R Nicholson2,3

  • 1Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

PubMed

Insights

Children with inflammatory bowel disease (IBD) face higher rates of Clostridioides difficile infection (CDI). Current diagnostic tests are insufficient, and specialized care is crucial for managing this vulnerable population.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Microbiome Research

Background:

  • Children with inflammatory bowel disease (IBD) exhibit an increased susceptibility to Clostridioides difficile infection (CDI).
  • Outcomes for pediatric IBD patients with CDI are often more severe compared to the general pediatric population.

Purpose of the Study:

  • To review current research on the incidence, diagnosis, complications, and treatment of CDI in pediatric IBD patients.
  • To highlight the unique challenges and considerations for managing CDI in this specific demographic.

Main Methods:

  • Literature review of recent studies on CDI in pediatric IBD.
  • Analysis of diagnostic accuracy and treatment efficacy for CDI in children with IBD.

Main Results:

  • Pediatric IBD patients show a higher incidence of CDI, independent of typical adult risk factors.
  • Current diagnostic methods struggle to distinguish CDI from colonization in this group.
  • Fecal microbiota transplantation demonstrates effectiveness for recurrent CDI.

Conclusions:

  • CDI is a significant concern in children with IBD, necessitating vigilant clinical monitoring.
  • Patients with co-occurring IBD and CDI require close surveillance for adverse outcomes.
  • Further research is essential to optimize diagnostic and therapeutic strategies for CDI in pediatric IBD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
285
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
152
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
213
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
973
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354